Top news
Onkologie

Hurvitz et al.: Sacituzumab Govitecan Efficacy in Patients with Metastatic Triple-Negative Breast Cancer by HER2 Immunohistochemistry Status: Findings from the Phase 3 ASCENT Study

03.-05.05.2022 / ESMO BC 2022

Mehr lesen